Details
| Stereochemistry | RACEMIC |
| Molecular Formula | 2C10H15NO.H2O4S |
| Molecular Weight | 428.543 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.CNC(C)CC1=CC=C(O)C=C1.CNC(C)CC2=CC=C(O)C=C2
InChI
InChIKey=WUORSSYNZWHFQY-UHFFFAOYSA-N
InChI=1S/2C10H15NO.H2O4S/c2*1-8(11-2)7-9-3-5-10(12)6-4-9;1-5(2,3)4/h2*3-6,8,11-12H,7H2,1-2H3;(H2,1,2,3,4)
| Molecular Formula | C10H15NO |
| Molecular Weight | 165.2322 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Pholedrine is a hydroxymethylamphetamine. It is a sympathimimetric drug of low toxicity, which is of great value in conditions of hypotonia, collapse, and circulatory depression. Pholedrine was reported on in 1937 by several investigators, who described its vasopressor action in animals as more potent than that of ephedrine. The drug is grouped with hydroxyamphetamine because of its similarity in structure and hemodynamic pattern. Pholedrine, in small doses, potentiates epinephrine, but in large doses blocks its pressor effect. Pholedrine applied as eye-drops produces mydriasis that is greatly attenuated by guanethidine pretreatment and diminished in patients with postganglionic sympathetic nerve lesions. It might be used to diagnose Horner's syndrome.
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
60.7 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/10348201/ |
40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered: |
PHOLEDRINE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats. | 2006-05-17 |
|
| Direct determination of p-hydroxymethamphetamine glucuronide in human urine by high-performance liquid chromatography. | 2006-04 |
|
| LC-MS/MS analysis of pholedrine in a fatal intoxication case. | 2003-04-23 |
|
| Interactions of amphetamine analogs with human liver CYP2D6. | 1997-06-01 |
|
| Simultaneous determination of methamphetamine and its metabolites in monkey urine by gas chromatography/mass spectrometry with selected ion monitoring. | 1989-03-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:10 GMT 2025
by
admin
on
Mon Mar 31 17:48:10 GMT 2025
|
| Record UNII |
WB6LNL73BR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
37718-01-7
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
SUPERSEDED | |||
|
93020
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
100000085301
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
m8712
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
6114-26-7
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
228-083-0
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
236644
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
953-38-8
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
SUPERSEDED | |||
|
WB6LNL73BR
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
SUB03790MIG
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY | |||
|
96983
Created by
admin on Mon Mar 31 17:48:10 GMT 2025 , Edited by admin on Mon Mar 31 17:48:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |